Brief: Viracta Therapeutics Reports First Quarter 2022 Results
May 10 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND RECENT UPDATES
* Q1 LOSS PER SHARE $0.28
* Q1 EARNINGS PER SHARE VIEW $-0.32 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn49WMMwa
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update